ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative is a research paper published in Cancer Chemotherapy and Pharmacology (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Maryland Technology Development Corporation
Grant: Project 1120-005
Maryland Industrial Partnerships
Grant: Project 6502
National Institutes of Health
Grant: T32GM066691
National Institutes of Health
Grant: P30CA006973
National Institutes of Health
Grant: UL1TR003098
National Institutes of Health
Grant: S10RR026824
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 1S10RR026824-01
UPLC with Tandem MS for Sensitive Quantitative Analysis of Small Molecules
National Institutes of Health
Grant: 5UL1TR003098-02
Johns Hopkins Institute for Clinical and Translational Research
National Institutes of Health
Grant: 5T32GM066691-18
Clinical Pharmacology Training Program
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals